Franklin Financial Q2: Net Income Climbs 12%, but Nonperforming Loans Double
FRAF sits 63% above its 52-week low of $38.52.
Summary
Franklin Financial reported Q2 net income of $6.6 million ($1.47/share), up 11.9% year-over-year, but nonperforming loans surged to $17.7 million from $8.5 million at year-end 2025, concentrated in two large CRE loans. The bank increased its provision for credit losses and specific reserves.
Key Events · Earnings and Guidance · FRAF
-
Q2 Net Income Rises 11.9%
Net income reached $6.6 million ($1.47 diluted EPS), compared with $5.9 million ($1.32) a year ago, driven by a 12.2% increase in net interest income to $19.3 million.
-
Nonperforming Loans Double
Nonperforming loans jumped to $17.7 million (1.1% of gross loans) from $8.5 million at year-end 2025, primarily due to an $8.8 million CRE participation loan placed on nonaccrual and a $7.0 million matured construction loan.
-
Provision for Credit Losses Spikes
The provision for credit losses on loans was $1.6 million in Q2, versus $704 thousand a year ago, reflecting increased specific reserves on the two troubled CRE credits.
-
Net Interest Margin Expands
NIM widened to 3.50% from 3.21% a year ago, as deposit costs fell to 1.50% from 1.95%, more than offsetting a slight decline in earning-asset yields.
Analysis · FRAF · Finance
Franklin Financial delivered robust second-quarter results, with net income advancing 11.9% to $6.6 million, fueled by a wider net interest margin and lower deposit costs. Yet credit quality deteriorated sharply — nonperforming loans more than doubled from year-end to $17.7 million, concentrated in two large commercial real estate credits. The bank responded by increasing its specific reserves and provision, signaling rising stress in its CRE portfolio. With the stock trading near its 52-week high, the market may be pricing in the earnings strength while underappreciating the credit risk.
At the time of this filing, FRAF was trading at $62.81 on NASDAQ in the Finance sector, with a market capitalization of approximately $282.2M. The 52-week trading range was $38.52 to $64.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.